Pravin U Dugel, Adrian Koh, Yuichiro Ogura, Glenn J Jaffe, Ursula Schmidt-Erfurth, David M Brown, Andre V Gomes, James Warburton, Andreas Weichselberger, Frank G Holz. Ophthalmology 2020
Times Cited: 272
Times Cited: 272
Times Cited
Times Co-cited
Similarity
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Pravin U Dugel, Rishi P Singh, Adrian Koh, Yuichiro Ogura, Georges Weissgerber, Kinfemichael Gedif, Glenn J Jaffe, Ramin Tadayoni, Ursula Schmidt-Erfurth, Frank G Holz. Ophthalmology 2021
Pravin U Dugel, Rishi P Singh, Adrian Koh, Yuichiro Ogura, Georges Weissgerber, Kinfemichael Gedif, Glenn J Jaffe, Ramin Tadayoni, Ursula Schmidt-Erfurth, Frank G Holz. Ophthalmology 2021
41
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
31
Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
25
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
Caroline R Baumal, Richard F Spaide, Lejla Vajzovic, K Bailey Freund, Scott D Walter, Vishak John, Ryan Rich, Nauman Chaudhry, Rohit R Lakhanpal, Patrick R Oellers,[...]. Ophthalmology 2020
Caroline R Baumal, Richard F Spaide, Lejla Vajzovic, K Bailey Freund, Scott D Walter, Vishak John, Ryan Rich, Nauman Chaudhry, Rohit R Lakhanpal, Patrick R Oellers,[...]. Ophthalmology 2020
26
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, Ramin Tadayoni, Thomas A Albini, Peter K Kaiser, Frank G Holz, Jean-Francois Korobelnik, Ivana K Kim, Christian Pruente,[...]. Ophthalmology 2021
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, Ramin Tadayoni, Thomas A Albini, Peter K Kaiser, Frank G Holz, Jean-Francois Korobelnik, Ivana K Kim, Christian Pruente,[...]. Ophthalmology 2021
36
Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.
Sara J Haug, Doan Luong Hien, Gunay Uludag, Than Trong Tuong Ngoc, Sherin Lajevardi, M Sohail Halim, Yasir J Sepah, Diana V Do, Arshad M Khanani. Am J Ophthalmol Case Rep 2020
Sara J Haug, Doan Luong Hien, Gunay Uludag, Than Trong Tuong Ngoc, Sherin Lajevardi, M Sohail Halim, Yasir J Sepah, Diana V Do, Arshad M Khanani. Am J Ophthalmol Case Rep 2020
34
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
21
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration.
Quan Dong Nguyen, Arup Das, Diana V Do, Pravin U Dugel, Andre Gomes, Frank G Holz, Adrian Koh, Carolyn K Pan, Yasir J Sepah, Nikhil Patel,[...]. Ophthalmology 2020
Quan Dong Nguyen, Arup Das, Diana V Do, Pravin U Dugel, Andre Gomes, Frank G Holz, Adrian Koh, Carolyn K Pan, Yasir J Sepah, Nikhil Patel,[...]. Ophthalmology 2020
32
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Andre J Witkin, Paul Hahn, Timothy G Murray, J Fernando Arevalo, Kevin J Blinder, Netan Choudhry, Geoff G Emerson, Roger A Goldberg, Stephen J Kim, Joel Pearlman,[...]. J Vitreoretin Dis 2020
Andre J Witkin, Paul Hahn, Timothy G Murray, J Fernando Arevalo, Kevin J Blinder, Netan Choudhry, Geoff G Emerson, Roger A Goldberg, Stephen J Kim, Joel Pearlman,[...]. J Vitreoretin Dis 2020
29
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Frank G Holz, Pravin U Dugel, Georges Weissgerber, Robin Hamilton, Rufino Silva, Francesco Bandello, Michael Larsen, Andreas Weichselberger, Andreas Wenzel, Anne Schmidt,[...]. Ophthalmology 2016
Frank G Holz, Pravin U Dugel, Georges Weissgerber, Robin Hamilton, Rufino Silva, Francesco Bandello, Michael Larsen, Andreas Weichselberger, Andreas Wenzel, Anne Schmidt,[...]. Ophthalmology 2016
26
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
16
Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations.
Atul Jain, Sophaktra Chea, Wataru Matsumiya, M Sohail Halim, Çigdem Yaşar, Guoping Kuang, Yasir J Sepah, Arshad M Khanani, Diana V Do, Quan Dong Nguyen. Am J Ophthalmol Case Rep 2020
Atul Jain, Sophaktra Chea, Wataru Matsumiya, M Sohail Halim, Çigdem Yaşar, Guoping Kuang, Yasir J Sepah, Arshad M Khanani, Diana V Do, Quan Dong Nguyen. Am J Ophthalmol Case Rep 2020
35
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
Caroline R Baumal, Bahram Bodaghi, Michael Singer, David J Tanzer, András Seres, Mayur R Joshi, Nicolas Feltgen, Richard Gale. Ophthalmol Retina 2021
Caroline R Baumal, Bahram Bodaghi, Michael Singer, David J Tanzer, András Seres, Mayur R Joshi, Nicolas Feltgen, Richard Gale. Ophthalmol Retina 2021
42
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
15
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
Pravin U Dugel, Glenn J Jaffe, Peter Sallstig, James Warburton, Andreas Weichselberger, Mark Wieland, Lawrence Singerman. Ophthalmology 2017
Pravin U Dugel, Glenn J Jaffe, Peter Sallstig, James Warburton, Andreas Weichselberger, Mark Wieland, Lawrence Singerman. Ophthalmology 2017
15
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
15
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
15
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group.
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
14
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR : A Randomized Controlled Trial.
Masahito Ohji, Kanji Takahashi, Annabelle A Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano. Adv Ther 2020
Masahito Ohji, Kanji Takahashi, Annabelle A Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano. Adv Ther 2020
16
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
13
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
12
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
11
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Brandon G Busbee, Allen C Ho, David M Brown, Jeffrey S Heier, Ivan J Suñer, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2013
Brandon G Busbee, Allen C Ho, David M Brown, Jeffrey S Heier, Ivan J Suñer, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2013
11
Brolucizumab-early real-world experience: BREW study.
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Srinivas R Sadda, Giulia Corradetti, Jeffrey Heier, Adam T Chin, David Boyer, Pouya Dayani, Sruthi Arepalli,[...]. Eye (Lond) 2021
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Srinivas R Sadda, Giulia Corradetti, Jeffrey Heier, Adam T Chin, David Boyer, Pouya Dayani, Sruthi Arepalli,[...]. Eye (Lond) 2021
50
Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.
Rufino Silva, András Berta, Michael Larsen, Wayne Macfadden, Chrystel Feller, Jordi Monés. Ophthalmology 2018
Rufino Silva, András Berta, Michael Larsen, Wayne Macfadden, Chrystel Feller, Jordi Monés. Ophthalmology 2018
11
Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang. Ophthalmology 2013
Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang. Ophthalmology 2013
10
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.
Derek Kunimoto, Young Hee Yoon, Charles C Wykoff, Andrew Chang, Rahul N Khurana, Raj K Maturi, Hansjürgen Agostini, Eric Souied, David R Chow, Andrew J Lotery,[...]. Ophthalmology 2020
Derek Kunimoto, Young Hee Yoon, Charles C Wykoff, Andrew Chang, Rahul N Khurana, Raj K Maturi, Hansjürgen Agostini, Eric Souied, David R Chow, Andrew J Lotery,[...]. Ophthalmology 2020
27
Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results.
Charles C Wykoff, Daniel E Croft, David M Brown, Rui Wang, John F Payne, Lloyd Clark, Nizar Saleh Abdelfattah, SriniVas R Sadda. Ophthalmology 2015
Charles C Wykoff, Daniel E Croft, David M Brown, Rui Wang, John F Payne, Lloyd Clark, Nizar Saleh Abdelfattah, SriniVas R Sadda. Ophthalmology 2015
9
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
9
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
9
Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
Ursula Schmidt-Erfurth, Sebastian M Waldstein, Gabor-Gyoergy Deak, Michael Kundi, Christian Simader. Ophthalmology 2015
Ursula Schmidt-Erfurth, Sebastian M Waldstein, Gabor-Gyoergy Deak, Michael Kundi, Christian Simader. Ophthalmology 2015
9
Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor Agents.
Rebecca N Evans, Barnaby C Reeves, Maureen G Maguire, Daniel F Martin, Alyson Muldrew, Tunde Peto, Chris Rogers, Usha Chakravarthy. JAMA Ophthalmol 2020
Rebecca N Evans, Barnaby C Reeves, Maureen G Maguire, Daniel F Martin, Alyson Muldrew, Tunde Peto, Chris Rogers, Usha Chakravarthy. JAMA Ophthalmol 2020
25
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.
Peter A Campochiaro, Dennis M Marcus, Carl C Awh, Carl Regillo, Anthony P Adamis, Vladimir Bantseev, Yawen Chiang, Jason S Ehrlich, Signe Erickson, William D Hanley,[...]. Ophthalmology 2019
Peter A Campochiaro, Dennis M Marcus, Carl C Awh, Carl Regillo, Anthony P Adamis, Vladimir Bantseev, Yawen Chiang, Jason S Ehrlich, Signe Erickson, William D Hanley,[...]. Ophthalmology 2019
9
Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study.
Jonathan L Prenner, Lawrence S Halperin, Catherine Rycroft, Susan Hogue, Zinaria Williams Liu, Robert Seibert. Am J Ophthalmol 2015
Jonathan L Prenner, Lawrence S Halperin, Catherine Rycroft, Susan Hogue, Zinaria Williams Liu, Robert Seibert. Am J Ophthalmol 2015
11
Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy.
Hidetaka Matsumoto, Junki Hoshino, Ryo Mukai, Kosuke Nakamura, Hideo Akiyama. Sci Rep 2021
Hidetaka Matsumoto, Junki Hoshino, Ryo Mukai, Kosuke Nakamura, Hideo Akiyama. Sci Rep 2021
50
Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study.
Louisa Maria Bulirsch, Marlene Saßmannshausen, Jennifer Nadal, Raffael Liegl, Sarah Thiele, Frank G Holz. Br J Ophthalmol 2021
Louisa Maria Bulirsch, Marlene Saßmannshausen, Jennifer Nadal, Raffael Liegl, Sarah Thiele, Frank G Holz. Br J Ophthalmol 2021
42
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration.
Ana Bety Enríquez, Caroline R Baumal, Ashley M Crane, Andre J Witkin, David R Lally, Michelle C Liang, José Ramón Enríquez, David A Eichenbaum. JAMA Ophthalmol 2021
Ana Bety Enríquez, Caroline R Baumal, Ashley M Crane, Andre J Witkin, David R Lally, Michelle C Liang, José Ramón Enríquez, David A Eichenbaum. JAMA Ophthalmol 2021
45
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Sarah Wordsworth, Barnaby C Reeves. Ophthalmology 2012
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Sarah Wordsworth, Barnaby C Reeves. Ophthalmology 2012
8
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sumit Sharma, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Maureen G Maguire, Gui-Shuang Ying, Jiayan Huang, Daniel F Martin, Glenn J Jaffe. Ophthalmology 2016
Sumit Sharma, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Maureen G Maguire, Gui-Shuang Ying, Jiayan Huang, Daniel F Martin, Glenn J Jaffe. Ophthalmology 2016
8
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
Jayashree Sahni, Sunil S Patel, Pravin U Dugel, Arshad M Khanani, Chirag D Jhaveri, Charles C Wykoff, Vrinda S Hershberger, Meike Pauly-Evers, Shamil Sadikhov, Piotr Szczesny,[...]. Ophthalmology 2019
Jayashree Sahni, Sunil S Patel, Pravin U Dugel, Arshad M Khanani, Chirag D Jhaveri, Charles C Wykoff, Vrinda S Hershberger, Meike Pauly-Evers, Shamil Sadikhov, Piotr Szczesny,[...]. Ophthalmology 2019
8
Innovative therapies for neovascular age-related macular degeneration.
Hasenin Al-Khersan, Rehan M Hussain, Thomas A Ciulla, Pravin U Dugel. Expert Opin Pharmacother 2019
Hasenin Al-Khersan, Rehan M Hussain, Thomas A Ciulla, Pravin U Dugel. Expert Opin Pharmacother 2019
15
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Glenn J Jaffe, Daniel F Martin, Cynthia A Toth, Ebenezer Daniel, Maureen G Maguire, Gui-Shuang Ying, Juan E Grunwald, Jiayan Huang. Ophthalmology 2013
Glenn J Jaffe, Daniel F Martin, Cynthia A Toth, Ebenezer Daniel, Maureen G Maguire, Gui-Shuang Ying, Juan E Grunwald, Jiayan Huang. Ophthalmology 2013
6
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Allen C Ho, Brandon G Busbee, Carl D Regillo, Mark R Wieland, Sherri A Van Everen, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2014
Allen C Ho, Brandon G Busbee, Carl D Regillo, Mark R Wieland, Sherri A Van Everen, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2014
6
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
6
Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Mark C Gillies, Alex P Hunyor, Jennifer J Arnold, Robyn H Guymer, Sebastian Wolf, Paul Ng, Francois L Pecheur, Ian L McAllister. JAMA Ophthalmol 2019
Mark C Gillies, Alex P Hunyor, Jennifer J Arnold, Robyn H Guymer, Sebastian Wolf, Paul Ng, Francois L Pecheur, Ian L McAllister. JAMA Ophthalmol 2019
9
Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol.
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
6
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
6
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.
Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P Rosconi, Ergang Shi, Erica A Pyles, George D Yancopoulos, Neil Stahl, Stanley J Wiegand. Angiogenesis 2012
Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P Rosconi, Ergang Shi, Erica A Pyles, George D Yancopoulos, Neil Stahl, Stanley J Wiegand. Angiogenesis 2012
6
VEGF-Trap: a VEGF blocker with potent antitumor effects.
Jocelyn Holash, Sam Davis, Nick Papadopoulos, Susan D Croll, Lillian Ho, Michelle Russell, Patricia Boland, Ray Leidich, Donna Hylton, Elena Burova,[...]. Proc Natl Acad Sci U S A 2002
Jocelyn Holash, Sam Davis, Nick Papadopoulos, Susan D Croll, Lillian Ho, Michelle Russell, Patricia Boland, Ray Leidich, Donna Hylton, Elena Burova,[...]. Proc Natl Acad Sci U S A 2002
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.